- Description
- Curriculum
- FAQ
This latest course from MJ Clinical Training expands on the knowledge and information within our full GLP-1 agonist and weight management training. Bringing you the most up to date information on new treatments currently, or soon to be available in this category of pharmacological weight loss interventions. On completion of this course you will have the updated knowledge needed for prescribing both Wegovy(semaglutide) and Mounjaro(tirzepatide).
Note: This course is a supplement to our GLP-1 agonist and weight management training and must be read in conjunction with it. It is not a stand alone course and does not cover all aspects of GLP-1 agonist use in weight management. Professionals that have completed GLP-1 agonist and weight management training elsewhere may also benefit from this supplemental training.
-
2
Wegovy SPC and PILWegovy manufacturer Summary of Product Characteristics and patient information leaflet as published in the European Medicines Compendium.
-
3
Mounjaro SPC and PIL
Mounajaro manufacturer summary of product characteristics and patient information leaflet as published in the European Medicines Compendium.
-
4
Mounjaro Kwikpen instructions
How to use the Monjaro Kwikpen device
-
5
Wegovy and Mounjaro P-Formula
Condensed practicial prescribing information for Wegovy and Mounjaro
-
6
Wegovy and Mounjaro dosing
Specific dosing protocols for Wegovy and Mounjaro
-
7
Risk assessment and expectation
